The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study)

Inclusion Criteria: * Woman who is between 20\~80 years of age. * Woman who is reserved with total laparoscopic hysterectomy like: * Malignant neoplasm of cervix * Malignant neoplasm of uterine body * Unspecified malignant neoplasm of cervical region * Other and unspecified malignant neoplasm of the female reproductive system * Carcinoma in situ of the cervix * Other and unspecified carcinoma in situ of the reproductive system Leiomyoma of the uterus * Other benign neoplasms of uterus * Neoplasm of uncertain behavior of uterus * Endometriosis * Polyp of corpus uteri * Other noninflammatory disorders of uterus, except cervix * Cervical dysplasia * Congenital malformations of uterus and cervix * Injury of uterus * Woman who signed and informed consent. Exclusion Criteria: * Presence of tumor or inflammatory disease in other organs after the laparoscopy or laparoscopic surgery * Subjects with a history of open surgery or laparoscopic surgery * Subject who is not eligible for anesthesia or re-operation due to other disease confirmed by investigator * Subject who is not eligible for re-operation or laparoscopy after laparoscopic surgery * Subjects using coagulant and subjects with lymphoid disease * Diabetic subjects administrating oral or parenteral glucose-lowering drugs * Patients with autoimmune diseases or immune disorders * Liver disease or kidney disease, surgical subjects including open surgery of gastrointestinal or urinary system * Subject…